Primary pulmonary hypertension is a rare but potentially fatal condition of the lungs
Our GLP-1 weight loss program is designed for adults who: Have a BMI of 30 or higher, or Have a BMI of 27 or above with a related condition such as high blood pressure, type 2 diabetes, prediabetes, thyroid issues, or PCOS, or Are struggling with weight gain related to perimenopause or post-menopause Have tried lifestyle changes without achieving sustainable results A medical assessment is required before starting the program to confirm the treatment is safe and appropriate for your health history
Patients may feel the medication works less dramatically over time because they have adapted to its effects
Participants discontinuing treatment prematurely remained in the trial and were encouraged to attend scheduled visits, particularly those at weeks 104 and 111
For those denied GLP-1 coverage altogether, other oral alternatives like Qsymia and Contrave may be worth exploring
So, what exactly are these medications everyones buzzing about, Ozempic, Wegovy, and Mounjaro